Print this article
Wealth Manager In Florida Admits Insider Trading
Sandra Kilhof
1 October 2013
A former advisor and executive at a global wealth management
firm has pleaded guilty in a US
federal court to insider trading charges related to Gilead Sciences' $11 billion
acquisition of Pharmasset. The US said Kevin Dowd,
38, of Boca Raton, FL, used non-public information about the
impending deal to tip off two friends and investors who made about $700,000 in
total profit off of trades based on the tips. According to the SEC, Dowd attained the information when a
board member of Pharmasset, who was the largest customer of the wealth
management firm for which Dowd worked, let it slip that Gilead
had an upcoming offer for Pharmasset. On November 18, 2011, three days before the offer was
announced, Dowd’s two investors offered $137 per share in cash, representing a
premium of about 89 per cent over Pharmasset's closing price, the US Department of Justice
added. The investors then liquidated their positions after the deal
was announced. Dowd himself admitted to receiving $35,000 in exchange for
the tip, according to US
attorney Paul Fishman. Consequently, Dowd pleaded guilty to conspiracy to commit
securities fraud and faces up to five years in prison and a fine of $250,000
when he is sentenced on January 15, 2014.